Literature DB >> 22816013

A study of the changes in the cause of peptic ulcer bleeding.

Haruka Fujinami1, Takahiko Kudo, Ayumu Hosokawsa, Kohei Ogawa, Takako Miyazaki, Jun Nishikawa, Shinya Kajiura, Takayuki Ando, Akira Ueda, Toshiro Sugiyama.   

Abstract

AIM: To clarify the frequency of and changes in the cause of peptic ulcer bleeding.
METHODS: This study retrospectively evaluated the out- and inpatients who underwent endoscopy between 2002 to 2008. The subjects were patients presenting with peptic ulcer bleeding. The details of these patients were obtained from their endoscopic reports and medical records.
RESULTS: The rates of Helicobacter pylori (H. pylori) infection were significantly low (P = 0.039), while the proportion of nonsteroidal antiinflammatory drugs (NSAIDs) users and vascular disease significantly increased over the period studied (P = 0.034 and P = 0.04, respectively). However, there was no significant difference in the proportion of low-dose aspirin users (P = 0.832).
CONCLUSION: It's found that the primary cause of peptic ulcer bleeding changed from H. pylori infection to use of NSAIDs over the 7-year period of study. It seems that the number of low-dose aspirin users has increased with the increase in the proportion of vascular disease. It is necessary to take measures to prevent peptic ulcer bleeding among NSAIDs and low dose aspirin users.

Entities:  

Keywords:  Gastroduodenal ulcer; Helicobacter pylori; Low-dose aspirin; Nonsteroidal antiinflammatory drugs; Peptic ulcer bleeding

Year:  2012        PMID: 22816013      PMCID: PMC3399011          DOI: 10.4253/wjge.v4.i7.323

Source DB:  PubMed          Journal:  World J Gastrointest Endosc


  37 in total

1.  Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.

Authors:  A Lanas; L A García-Rodríguez; M T Arroyo; F Gomollón; F Feu; A González-Pérez; E Zapata; G Bástida; L Rodrigo; S Santolaria; M Güell; C M de Argila; E Quintero; F Borda; J M Piqué
Journal:  Gut       Date:  2006-05-10       Impact factor: 23.059

2.  Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.

Authors:  A Lanas; E Bajador; P Serrano; J Fuentes; S Carreño; J Guardia; M Sanz; M Montoro; R Sáinz
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

Review 3.  Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s.

Authors:  S Hernández-Díaz; L A Rodríguez
Journal:  Arch Intern Med       Date:  2000-07-24

4.  Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.

Authors:  Hibiki Ootani; Ryuichi Iwakiri; Ryo Shimoda; Shin Nakahara; Sadahiro Amemori; Takehiro Fujise; Atsushi Kikkawa; Seiji Tsunada; Hiroyuki Sakata; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

5.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

6.  Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study.

Authors:  Jesper Hallas; Michael Dall; Alin Andries; Birthe Søgaard Andersen; Claus Aalykke; Jane Møller Hansen; Morten Andersen; Annmarie Touborg Lassen
Journal:  BMJ       Date:  2006-09-19

7.  Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.

Authors:  F E Silverstein; D Y Graham; J R Senior; H W Davies; B J Struthers; R M Bittman; G S Geis
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

Review 8.  Comparative toxicity of non-steroidal anti-inflammatory agents.

Authors:  G Singh; D R Ramey; D Morfeld; J F Fries
Journal:  Pharmacol Ther       Date:  1994 Apr-May       Impact factor: 12.310

Review 9.  Low-dose aspirin-induced gastrointestinal diseases: past, present, and future.

Authors:  Akiko Shiotani; Tomoari Kamada; Ken Haruma
Journal:  J Gastroenterol       Date:  2008-08-17       Impact factor: 7.527

Review 10.  Epidemiology and clinical characteristics of GERD in the Japanese population.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-04-14       Impact factor: 7.527

View more
  1 in total

Review 1.  Diagnosis, treatment, and outcome in patients with bleeding peptic ulcers and Helicobacter pylori infections.

Authors:  Ting-Chun Huang; Chia-Long Lee
Journal:  Biomed Res Int       Date:  2014-06-30       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.